This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been approved based on an objective…
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York CrazyBulk proudly announces the release of…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- FY Energy, a global platform known for delivering encrypted, renewable-powered…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As the crypto industry experiences a new wave of mainstream…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As a historic shift in blockchain capital unfolds, FY Energy,…
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action -- August 31, 2025 08:30 ET | Source: Amarin…
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…
RIYADH, Saudi Arabia, Aug. 30, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC), ranked 15th globally…
New Jersey City, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amid growing institutional participation and regulatory milestones in the cryptocurrency sector,…
New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- In response to Ethereum’s historic performance this month, FY Energy is…